Palm oil vitamin e tested as Anti-Aging pill in 220 volunteers

NCT ID NCT07637487

Recruiting now Disease control Sponsor: National University of Malaysia Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This phase 2 trial is testing whether a daily dose of tocotrienol, a form of vitamin E from palm oil, can reduce markers of aging in healthy adults aged 35 to 64. Over 6 months, 220 participants will take either tocotrienol or a placebo. Researchers will measure changes in cellular aging, inflammation, and overall health to see if the supplement can promote healthier aging.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: tocotrienol-rich fraction (a form of vitamin E from palm oil)
What this could lead to: If it works, this could point toward a simple supplement to promote healthier aging and reduce the risk of age-related diseases.
What could go wrong: This is an early-phase trial in healthy people, so results may not apply to those with existing conditions. The supplement may have no effect on aging markers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY

Contacts and locations

Locations

National University of Malaysia
RECRUITING

Kuala Lumpur, Kuala Lumpur, 56000, Malaysia

More trials for these conditions

Other studies related to the condition(s) this trial covers.